And there is a chart of the poor results of Remdesivir on the link below.
NEW Research—First randomised trial of #remdesivir for hospitalised patients who are critically ill with #COVID19 suggests antiviral drug is not associated with significant clinical benefits vs placebo: study of 237 adults from 10 hospitals in Wuhan (1/5) https://hubs.ly/H0p-BMJ0
Actually, considering the sickness of the patients, and the underpowering of the study, the results are somewhat promising.